Michael Blaiss

May 13, 2024 | healio.com | Victoria Langowska |Kristen Dowd |Michael Blaiss

Michael S. Blaiss, MD, FACAAI, FAAAAI The findings from this real-world data Germany study confirm previous studies that subcutaneous allergen immunotherapy with house dust mite can lead to immunomodulation and decrease the need for AR treatment and the development or time of onset of asthma. It is important to note that in this study that a house dust mite depot immunotherapy containing aluminum hydroxide was used that is not available in the United States.

Apr 18, 2024 | healio.com | Richard Gawel |Kristen Dowd |Michael Blaiss

You've successfully added Food Allergy to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: The review included 11 trials and more than 6,000 patients. Improvements included symptoms, sleep, emotions, problems and activities. Scores remained significant after accounting for age and sex.

Mar 7, 2024 | ep.bmj.com | Jay Lieberman |Antonella Muraro |Michael Blaiss

How to diagnose IgE-mediated food allergy Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Jan 10, 2024 | healio.com | Richard Gawel |Michael Blaiss |Kristen Dowd

You've successfully added Allergy/Asthma: Asthma and Respiratory Disorders to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways:Blaiss’ concerns include the lack of insurance coverage for many Americans. Asthma and atopic dermatitis present a high burden of disease.

Jul 20, 2023 | notiulti.com | Michael Blaiss

Michael S. Blaiss, MD, FACAAI, FAAAAIEste estudio continúa la investigación que muestra los efectos de la inmunoterapia con alérgenos como tratamiento modificador de la enfermedad para el asma alérgico y la rinitis. Se suma a nuestra comprensión de la acción de la inmunoterapia con alérgenos sobre los mediadores involucrados en las infecciones virales en nuestros pacientes atópicos.